Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

GZ-793A

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Methamphetamine is a potent psychostimulant with high abuse rates. Currently, there is no Food and Drug Administration-approved… Expand
Is this relevant?
2017
2017
ABSTRACT Lobeline and lobelane inhibit the behavioral and neurochemical effects of methamphetamine via an interaction with the… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Review
2014
Review
2014
Methamphetamine abuse escalates, but no approved therapeutics are available to treat addicted individuals. Methamphetamine… Expand
Is this relevant?
2013
2013
Despite the high prevalence of use of methamphetamine (METH), there is no FDA-approved pharmacological treatment available… Expand
Is this relevant?
2013
2013
Vesicular monoamine transporter-2 (VMAT2) inhibitors reduce methamphetamine (METH) reward in rats. The current study determined… Expand
Is this relevant?
2013
2013
(R)-3-[2,6-cis-Di(4-methoxyphenethyl)piperidin-1-yl]propane-1,2-diol (GZ-793A) inhibits methamphetamine-evoked dopamine release… Expand
Is this relevant?
2013
2013
Central heterocyclic ring size reduction from piperidinyl to pyrrolidinyl in the vesicular monoamine transporter-2 (VMAT2… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2012
2012
RationaleThe vesicular monoamine transporter 2 (VMAT2) has been identified as a potential target for the treatment of… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2011
2011
RationalePrevious research suggests that the vesicular monoamine transporter-2 (VMAT2) is a novel target for the treatment of… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
2011
2011
Lobelane, a chemically defunctionalized saturated analog of lobeline, has increased selectivity for the vesicular monoamine… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?